Novel Life Science Reagents
Product Name | CAS No. | Specification | Application | Registration |
Remdesivir (GS-5734) | 1809249-37-3 | |||
Atazanavir-D6 | 1092540-50-5 | |||
Bexarotene-D4 | 2182068-00-2 | |||
Oseltamivir-D5 Phosphate | ||||
Aflibercept | 862111-32-8 | |||
Cobimetinib (GDC-0973; XL518) | 934660-93-2 | |||
(+)-PD 128907 Hydrochloride | 300576-59-4 | |||
Sulopenem Etzadroxil & Intermediates | 1000296-70-7 | |||
Lurbinectedin (PM01183) & Intermediates | 497871-47-3 | |||
Trabectedin (Ecteinascidin 743) & Intermediates | 114899-77-3 | |||
Necrosulfonamide | 1360614-48-7 | 98%+ HPLC | ||
Temsirolimus (CCI-779) | 162635-04-3 | 98% Min. | ||
Alvespimycin (17-DMAG) HCl | 467214-21-7 | |||
Reparixin L-lysine salt (Repertaxin L-lysine salt) | 266359-93-7 | 98%+;ee-98%+ | ||
Resatorvid (TAK-242) | 243984-11-4 | In-House Standard |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks